These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 22467861

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes.
    Asada A, Yamamoto N, Gohda M, Saito T, Hayashi N, Hisanaga S.
    J Neurochem; 2008 Aug; 106(3):1325-36. PubMed ID: 18507738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S, Saito T.
    Neurosignals; 2003 Aug; 12(4-5):221-9. PubMed ID: 14673209
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
    Kobayashi H, Saito T, Sato K, Furusawa K, Hosokawa T, Tsutsumi K, Asada A, Kamada S, Ohshima T, Hisanaga S.
    J Biol Chem; 2014 Jul 11; 289(28):19627-36. PubMed ID: 24872417
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.
    Saito T, Yano M, Kawai Y, Asada A, Wada M, Doi H, Hisanaga SI.
    J Biol Chem; 2013 Nov 08; 288(45):32433-32439. PubMed ID: 24085300
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The protein SET binds the neuronal Cdk5 activator p35nck5a and modulates Cdk5/p35nck5a activity.
    Qu D, Li Q, Lim HY, Cheung NS, Li R, Wang JH, Qi RZ.
    J Biol Chem; 2002 Mar 01; 277(9):7324-32. PubMed ID: 11741927
    [Abstract] [Full Text] [Related]

  • 15. Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis.
    Lilja L, Johansson JU, Gromada J, Mandic SA, Fried G, Berggren PO, Bark C.
    J Biol Chem; 2004 Jul 09; 279(28):29534-41. PubMed ID: 15123626
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
    Dhavan R, Greer PL, Morabito MA, Orlando LR, Tsai LH.
    J Neurosci; 2002 Sep 15; 22(18):7879-91. PubMed ID: 12223541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.
    Humbert S, Dhavan R, Tsai L.
    J Cell Sci; 2000 Mar 15; 113 ( Pt 6)():975-83. PubMed ID: 10683146
    [Abstract] [Full Text] [Related]

  • 20. Identification of nuclear import mechanisms for the neuronal Cdk5 activator.
    Fu X, Choi YK, Qu D, Yu Y, Cheung NS, Qi RZ.
    J Biol Chem; 2006 Dec 22; 281(51):39014-21. PubMed ID: 17060323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.